FDA inspection

Lyofal: FDA inspection ending Mar 10, 2023

FDA inspection 1202238 · No Action Indicated (NAI) · Salon De Provence

Key facts

Inspection ID 1202238
Firm Lyofal
FEI number 3003364789
Address Synerlab Lyofal Za De La Gandonne, Rue Du Remoulaire
City Salon De Provence
Fiscal year 2023
Inspection end date Mar 10, 2023
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections